QQ客服 官方微博 反馈留言

	IMM-H007, a novel small molecule inhibitor for atherosclerosis, represses endothelium inflammation by regulating the activity of NF-κB and JNK/AP1 signaling
	Yu Jinjin; Ming Hong; Li Henry You; Yu Bin; Chu Maoping; Zhu Haibo; Zhu Xinxing
	2019
卷号	381页码:114732
关键词	Endothelium Inflammation H007 JNK/c-Jun Signaling NF-κB Signaling
ISSN号	1096-0333
DOI	10.1016/j.taap.2019.114732
URL标识	查看原文
收录类别	PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6338482
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Yu Jinjin,Ming Hong,Li Henry You,et al. IMM-H007, a novel small molecule inhibitor for atherosclerosis, represses endothelium inflammation by regulating the activity of NF-κB and JNK/AP1 signaling[J],2019,381:114732.
APA	Yu Jinjin.,Ming Hong.,Li Henry You.,Yu Bin.,Chu Maoping.,...&Zhu Xinxing.(2019).IMM-H007, a novel small molecule inhibitor for atherosclerosis, represses endothelium inflammation by regulating the activity of NF-κB and JNK/AP1 signaling.,381,114732.
MLA	Yu Jinjin,et al."IMM-H007, a novel small molecule inhibitor for atherosclerosis, represses endothelium inflammation by regulating the activity of NF-κB and JNK/AP1 signaling".381(2019):114732.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。